Compare CCBG & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCBG | MPLT |
|---|---|---|
| Founded | 1895 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.7M | 811.3M |
| IPO Year | 1994 | N/A |
| Metric | CCBG | MPLT |
|---|---|---|
| Price | $46.31 | $26.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $45.00 | $32.67 |
| AVG Volume (30 Days) | 100.0K | ★ 230.6K |
| Earning Date | 04-20-2026 | 05-28-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | ★ 3.60 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.25 | N/A |
| Revenue Next Year | $3.17 | N/A |
| P/E Ratio | $12.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.38 | $12.24 |
| 52 Week High | $46.92 | $29.55 |
| Indicator | CCBG | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 71.13 | 70.40 |
| Support Level | $41.41 | $16.19 |
| Resistance Level | $46.83 | N/A |
| Average True Range (ATR) | 1.00 | 2.10 |
| MACD | 0.39 | 0.95 |
| Stochastic Oscillator | 85.26 | 75.31 |
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.